代谢性心脏:将心力衰竭与保存的喷射部分重新定义为全身心脏代谢综合征
Debasrita Baidya1, Abhishek Hanumanpratap Singh Kshatri2, Emi K Zerzan3
1Biomedical Sciences, Indian Institute of Technology Patna, Bihta, IND.
Cureus
|February 4, 2026
概括
保持喷射分数 (HFpEF) 的心力衰竭是一种心脏代谢障碍. 针对新陈代谢途径的新疗法,如SGLT-2抑制剂和GLP-1激动剂,在传统治疗失败的地方显示出希望.
科学领域:
- 心脏病学 心脏病学
- 代谢障碍 代谢障碍 代谢障碍
- 药理学 药理学是指药理学的学科.
背景情况:
- 保存喷射分数 (HFpEF) 的心力衰竭越来越多地被认为是一种复杂的系统性心脏代谢障碍.
- 针对神经激素通路的传统治疗方法在异构的HFpEF群体中产生了中性结果.
研究的目的:
- 批判性地重新评估HFpEF作为一个全身心脏代谢障碍.
- 评估针对HFpEF中代谢途径的新型治疗策略的疗效.
主要方法:
- 来自PubMed,Scopus和Web of Science (2000-2025) 的文献的系统审查.
- 选了大约800个记录,优先考虑了108项研究,包括RCT,潜在队列和机制报告.
主要成果:
- 有证据表明内脏脂肪,胰岛素抵抗,慢性炎症和线粒体功能障碍会影响心脏能量.
- 在具有里程碑意义的RCT (EMPEROR-Preserved, DELIVER) 中,-葡萄糖携带载体-2 (SGLT-2) 抑制剂显示了住院和心血管事件的减少.
- 葡萄糖类-1 (GLP-1) 受体激动剂改善了症状,运动耐受性和体重.
结论:
- 代谢-炎症模式通过SGLT-2抑制剂和GLP-1受体激动剂的成功得到了验证.
- 持续的HFpEF异质性需要生物标志物驱动的表型,先进的成像和适应性试验设计,以提供精确的护理.
- 将代谢和生物能评估整合到HFpEF早期管理中至关重要.
相关概念视频
01:29Heart Failure II: Pathophysiology
948
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
948
01:17Pathophysiology of Heart Failure
3.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.7K
01:27Heart Failure I: Introduction
903
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
903
00:52What is Metabolism?
131.9K
Overview
131.9K
01:22Heart Failure VI: Adjunct Therapies
348
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
348
01:22Heart Failure Drugs: Diuretics
981
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
981